A review of strategies for enhancing the completeness of notifiable disease reporting

Journal of Public Health Management and Practice

Volumn 11, Issue 3, 2005, Pages 191-200

  Silk, Benjamin J ^a   Berkelman, Ruth L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

infectious disease reporting; review literature; surveillance

Indexed keywords

HEALTH SURVEY; HUMAN; INFECTION CONTROL; MEDICAL INFORMATICS; METHODOLOGY; PUBLIC RELATIONS; QUALITY CONTROL; REVIEW; UNITED STATES;

DISEASE NOTIFICATION; HUMANS; INTERPROFESSIONAL RELATIONS; POPULATION SURVEILLANCE; PUBLIC HEALTH INFORMATICS; QUALITY CONTROL; UNITED STATES;

EID: 18944407305     PISSN: 10784659     EISSN: 15505022     Source Type: Journal    
DOI: 10.1097/00124784-200505000-00003     Document Type: Article

References (76)

1. Roush S, Birkhead G, Koo D, Cobb A, Fleming D. Mandatory reporting of diseases and conditions by health care professionals and laboratories. JAMA. 1999;282(2):164-170.
2. Council of State and Territorial Epidemiologists. Nationally Notifiable Diseases Surveillance System Assessment 2001, state and territorial reporting profiles. Available at: http://www.cste.org/nndssmainmenu.htm. Accessed March 12, 2004.
3. Centers for Disease Control and Prevention. Nationally notifiable infectious diseases. Available at: http://www.cdc.gov/epo/dphsi/phs/infdis.htm. Accessed January 13, 2004.
4. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academy Press; 1992.
5. Osterholm MT, Birkhead GS, Merriwether RA. Impediments to public health surveillance in the 1990s: the lack of resources and the need for priorities. J Public Health Manag Pract. 1996;2(4):11-15.
6. Berkelman RL, Bryan RT, Osterholm MT, LeDuc JW, Hughes JM. Infectious disease surveillance: a crumbling foundation. Science. 1994;264:368-370.
7. Centers for Disease Control and Prevention. Addressing emerging infectious disease threats: a prevention strategy for the United States. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 1994.
8. Centers for Disease Control and Prevention. Preventing emerging infectious diseases: a strategy for the 21st century. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 1998.
9. Centers for Disease Control and Prevention. Infectious disease surveillance. Available at: http://www.cdc.gov/ncidod/osr/index.htm. Accessed January 14, 2004.
10. Centers for Disease Control and Prevention. Epidemiology and laboratory capacity for infectious diseases cooperative agreement. Available at: http://www.cdc.gov/ncidod/osr/site/epi_lab/index.htm. Accessed January 14, 2004.
11. Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis. 2003;9(7):781-787.
12. Centers for Disease Control and Prevention. Escherichia coli O157:H7 infections associated with eating a nationally distributed commercial brand of frozen ground beef patties and burgers—Colorado 1997. Morb Mortal Wkly Rep. 1997;46(33):777-778.
13. Centers for Disease Control and Prevention. Assessment of the epidemiologic capacity of state and territorial health departments-United States, 2001. Morb Mortal Wkly Rep. 2003;52(43):1049-1051.
14. US Government Accounting Office. HHS Bioterrorism Preparedness Programs: States Reported Progress but Fell Short of Program Goals for 2002. GAO-04-360R Washington, DC: US Government Accounting Office; February 10, 2004.
15. Mead PS, Slutsker L, Dietz V, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999;5(5):607-625.
16. Centers for Disease Control and Prevention. Updated guidelines for evaluating surveillance systems: recommendations from the Guidelines Working Group. Morb Mortal Wkly Rep. 2001;50 (RR-13):1-35.
17. Jones TF, Imhoff B, Samuel M, et al. Limitations to successful investigation and reporting of foodborne outbreaks: an analysis of foodborne disease outbreaks in FoodNet catchment areas, 1998-1999. Clin Infect Dis. 2004;38(Suppl 3):S297-S302.
18. Swaminathan B, Barrett TJ, Hunter SB, Tauxe RV. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg Infect Dis. 2001;7(3):382-389.
19. Doyle TJ, Glynn KM, Groseclose SL. Completeness of notifiable infectious reporting in the United States: an analytical literature review. Am J Epidemiol. 2002;155(9):866-874.
20. Curtis AB, McCray E, McKenna M, Onorato IM. Completeness and timeliness of tuberculosis case reporting. A multistate study. Am J Prev Med. 2001;20(2):108-112.
21. Ackman DM, Birkhead G, Flynn M. Assessment of surveillance for meningococcal disease in New York State, 1991. Am J Epidemiol. 1996;144(1):78-82.
22. Davis JP, Bohn MJ. The extent of under-reporting of meningococcal disease in Wisconsin: 1980-1982. WMJ. January 1984;83.
23. Standaert SM, Lefkowitz LB, Horan JM, Hutcheson RH, Schaffner W. The reporting of communicable diseases: a controlled study of Neisseria meningitidis and Haemophilus influenzae infections. Clin Infect Dis. 1995;20(1):30-36.
24. Pinner RW, Koo D, Berkelman RL. Surveillance of infectious diseases. In: Lederberg J, ed. Encyclopedia of Microbiology, 2nd ed. Washington, DC: Academic Press; 2000.
25. Schuchat A, Hilger T, Zell E, et al. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Emerg Infect Dis. 2001;7(1):92-99.
26. Tennessee Department of Health, Communicable and Environmental Disease Services. Notifiable diseases. Available at: http://www2.state.tn.us/health/CEDS/notifiable.htm. Accessed June 10, 2002.
27. Centers for Disease Control and Prevention. Case definitions for public health surveillance. Morb Mortal Wkly Rep. 1990;39(RR-13):1-43.
28. Chang MH, Glynn MK, Groseclose SL. Endemic, notifiable bioterrorism-related diseases, United States, 1992-1999. Emerg Infect Dis. 2003 May;9(5):556-564.
29. Vogt RL, LaRue D, Klaucke DN, Jillson DA. Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont. Am J Public Health. 1983;73(7):795-797
30. Thacker SB, Redmond S, Rothenberg RB, Spitz SS, Choi K, White MC. A controlled trial of disease surveillance strategies. Am J Prev Med. 1986;2(6):345-350.
31. Teutsch SM. Considerations for planning a surveillance system. In: Teutsch SM, Churchill RE, eds. Principles and Practice of Public Health Surveillance, 2nd ed. New York, NY: Oxford University Press; 2000.
32. Perz JF, Craig AS, Jorgensen DM, Hall S, Schaffner W. Evaluation of innovative surveillance for drug-resistant Streptococcus pneumoniae. Am J Epidemiol. 2001;154(11):1000-1005.
33. Backer HD, Bissell SR, Vugia DJ. Disease reporting from an automated laboratory-based reporting systems to a state health department via local county health departments. Public Health Rep. 2001;116(May-June 2001):257-265.
34. US Census Bureau. Georgia county selection map. Available at: http://quickfacts.census.gov/qfd/maps/georgia_map.html. Accessed October 21, 2002.
35. Metropolitan Atlanta Surveillance Task Force. Available at: http://www.mastf.net. Accessed March 12, 2004.
36. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. Morb Mortal Wkly Rep. 1997;46(RR-10):1-55.
37. Harkess JR, Gildon BA, Archer PW, Istre GR. Is passive surveillance always insensitive? An evaluation of shigellosis surveillance in Oklahoma. Am J Epidemiol. 1988;128(4):878-881.
38. Effler P, Ching-Lee M, Bogard A, Man-Cheng I, Nekomoto T, Jernigan D. Statewide system of electronic notifiable disease reporting from clinical laboratories: comparing automated reporting with conventional methods. JAMA. 1999;282(19):1845-1850.
39. Panackal A, M’ikanatha N, Tsui F-C, et al. Automatic electronic laboratory-based reporting of notifiable infectious diseases at a large health system. Emerg Infect Dis. 2002;8(7):685-691.
40. Centers for Disease Control and Prevention. Integrated Health Information and Surveillance Systems Board (HISSB): documents. Available at: http://www.cdc.gov/od/hissb/docs.htm. Accessed March 8, 2004.
41. Pinner RW, Jernigan DB, Sutliff SM. Electronic laboratory-based reporting for public health. Mil Med. 2000;165(Suppl 2):20-24.
42. M’ikanatha NM, Southwell B, Lautenbach E. Automated laboratory reporting of infectious diseases in a climate of bioterrorism. Emerg Infect Dis. 2003;9(9):1053-1057.
43. Institute of Medicine. Microbial Threats to Health: Emergence, Detection, and Response. Washington, DC: National Academy Press; 2003.
44. Konowitz PM, Petrossian GA, Rose DN. The underreporting of disease and physicians’ knowledge of reporting requirements. Public Health Rep. 1984;99:31-35.
45. Weiss BP, Strassburg MA, Fannin SL. Improving disease reporting in Los Angeles County: trial and results. Public Health Rep. 1988;103(4):415-421.
46. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N Engl J Med. 1994;330(14):949-955.
47. Fine A, Layton M. Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. Clin Infect Dis. 2001;32:277-282.
48. Bush LM, Abrams BH, Beall A, Johnson CC. Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl J Med. 2001;345(22):1607-1610.
49. Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: clinicians and public health agencies as essential partners. JAMA. 2002;287(7):898-900.
50. Ashford DA, Kaiser RM, Bales ME, et al. Planning against biological terrorism: lessons from outbreak investigations. Emerg Infect Dis. 2003;9(5):515-519.
51. Weiss D, Carr D, Kellachan J, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis. July-August 2001;7(4):654-658.
52. Centers for Disease Control and Prevention. Reporting of laboratory-confirmed chlamydial infection and gonorrhea by providers affiliated with three large managed care organizations—United States, 1995-1999. Morb Mortal Wkly Rep. 2002;51(12):256-259.
53. Division of Epidemiology and Immunization, Massachussetts Department of Public Health. Guide to surveillance and reporting. Available at: http://www.state.ma.us/dph/cdc/gsrman/gsr.htm. Accessed October 21, 2002.
54. Hackbarth A, Comit, C. et al. Guide to surveillance and reporting: an example of technical assistance for local health departments in Massachusetts. Paper presented at: International Conference on Emerging Infectious Diseases; March 24-27, 2002; Atlanta, GA.
55. Koplan JP, Harris JR. Not-so-strange bedfellows: public health and managed care. Am J Public Health. December 2000;90(12):1824-1826.
56. Institutute of Medicine. Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention, Workshop. Washington, DC: National Academy Press; 2000.
57. Rutherford GW. Public health, communicable diseases, and managed care: will managed care improve or weaken communicable disease control? Am J Prev Med 1998;14(3):53-59.
58. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol. 1985;121(2):182-205.
59. Murphy DM. From expert data collectors to interventionists: changing the focus for infection control professionals. Am J Infect Control. 2002;30(2):120-132.
60. Boyce J. Hospital epidemiology in smaller hospitals. Infect Control Hosp Epidemiol. 1995;16(10):600-606.
61. Bell BP, Goldoft M, Griffin PM, et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers: the Washington experience. JAMA. 1994;272(17):1349-1353.
62. Cieslak PR, Noble SJ, Maxson DJ, et al. Hamburger-associated Escherichia coli O157:H7 infection in Las Vegas: a hidden epidemic. Am J Public Health. 1997;87(2):176-180.
63. Centers for Disease Control and Prevention. Multistate outbreak of Escherichia coli O157:H7 infections from hamburgers—Western United States, 1992-1993. Morb Mortal Wkly Rep. 1993;42(14):258-263.
64. Centers for Disease Control and Prevention. Arboviral encephalitis cases reported in humans, by type, United States, 1964-2000. Available at: http://www.cdc.gov/ncidod/dvbid/arbor/arbocase.htm. Accessed February 13, 2003.
65. Koo D, Wetterhall SF. History and current status of the National Notifiable Diseases Surveillance System. J Public Health Manag Pract. 1996;2(4):4-10.
66. Centers for Disease Control and Prevention. Biological and chemical terrorism: strategic plan for preparedness and response, recommendations of the CDC Strategic Planning Workgroup. Morb Mortal Wkly Rep. 2000;49(RR-04):1-14.
67. Centers for Disease Control and Prevention. The public health response to biological and chemical terrorism: interim planning guidance for state public health officials. Available at: http://www.bt.cdc.gov/Documents/Planning/PlanningGuidance.PDF. Accessed July 27, 2004.
68. Chorba TL, Berkelman RL, Safford SK, Gibbs NP, Hull HF. Mandatory reporting of infectious diseases by clinicians. Morb Mortal Wkly Rep. 1990;39(RR-9):1-11,16-17
69. Shieh WJ, Guarner J, Layton M, et al. The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis. 2000;6(4):370-372.
70. Dumler JS, Valsamakis A. Molecular diagnostics for existing and emerging infections. Complementary tools for a new era of clinical microbiology. Am J Clin Pathol. 1999;112:S33-S39.
71. Buehler JW, Berkelman RL, Hartley DM, Peters CJ. Syndromic surveillance and bioterrorism-related epidemics. Emerg Infect Dis. 2003;9(10):1197-1204.
72. Centers for Disease Control and Prevention. Framework for evaluating public health surveillance systems for early detection of outbreaks. Morb Mortal Wkly Rep. 2004;53 (RR-05):1-11.
73. Reingold A. If syndromic surveillance is the answer, what is the question? Biosecur Bioterror Biodefense Strategy Pract Sci. 2003;1(2):77-81.
74. Sosin DM. Syndromic surveillance: the case for skillful investment. Biosecur Bioterror Biodefense Strategy Pract Sci 2003;1(4):247-253.
75. Department of Health and Human Services. FY 2005 budget in brief: departmental management. Available at: http://www.hhs.gov/budget/05budget/management.html. Accessed April 28, 2004.
76. National Research Council, Committee on Science and Technology for Countering Terrorism. Making the Nation Safer: The Role of Science and Technology in Countering Terrorism. Washington, DC: National Academy Press; 2002.